A robust patient education program may help decrease the risk of harmful outcomes, according to a study published in the Journal of Evaluation in Clinical Practice. Read the full report in Becker’s Hospital Review on patient education.
Uncategorized
A study performed in Canada suggests more expensive healthcare may lead to better patient outcomes, which is in stark contrast to research in the U.S., according to a Patriot-News report. Read the full report in Becker’s Hospital Review on the…
A report of sentinel events reviewed by The Joint Commission reveals unintended retention of a foreign object (188 events) and wrong-patient/wrong-site/wrong-procedure (152 events) were the most frequently occurring categories of sentinel events for 2011. Read the full report in Becker’s…
Occasionally, on an accreditation review, the AORN and ASA position of not using multiple dose vials in the operating room is commented on. At this junction, this is a recommendation — not a regulation.
SurgiTools, an Australia-based medical device manufacturer, has announced it has received 510(k) clearance from FDA to sell its Singh Colpotomizer System in the United States, according to a news release.
Advertisement
Sientra has announced that it has received FDA approval of its portfolio of Silimed-brand silicone breast implants, according to a news release.
Fifteen healthcare organizations, including Loma Linda University Medical Center, will participate in a national study designed to study how improvements in frontline care can boost patient outcomes. Read the full report in Becker’s Hospital Review on the Small Troubles, Adaptive…
Researchers from Mount Sinai Medical Center found 92.3 percent of survey respondents indicated production pressures, such as heightened demand for colonoscopies, rising overhead or shrinking reimbursement rates, resulted in physicians postponing, aborting or reducing the extent of a colonoscopy procedure.…
In an effort to boost patient engagement, Advanced Spinal Rehab in Lincoln, Neb., has launched a website to educate patients about chiropractic and physical therapy, the center announced.
U.S. drug regulators may allow companies to restart clinical trials centered on osteoarthritis painkillers that carry a risk of joint damage, according to a Reuters report.